Home NDC 0378-2042 Bromocriptine Mesylate
Product NDC 0378-2042
11-digit product format 003782042
Labeler code 0378
Product ID 0378-2042_74a65bb4-02b6-4c5f-baa6-a27086744f38
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name bromocriptine mesylate
Dosage form TABLET
Route ORAL
Labeler Mylan Pharmaceuticals Inc.
Application ANDA076962
Marketing category ANDA
Marketing start 2013-06-05
Marketing end 2020-07-31
Substance BROMOCRIPTINE MESYLATE
Active strength 3 mg/1
Pharmacologic classes Ergot Derivative [EPC],Ergolines [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076962-001 BROMOCRIPTINE MESYLATE BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2004-09-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2004-09-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2004-09-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2004-09-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A076962-001 BROMOCRIPTINE MESYLATE EQ 2.5MG BASE TABLET / ORAL 2004-09-24 cb3db0bc1861…
Observed Orange Book normalized TE history# DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded BROMOCRIPTINE MESYLATE ACTIVE INGREDIENT FFP983J3OD BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 BROMOCRIPTINE ACTIVE MOIETY 3A64E3G5ZO BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 ANHYDROUS LACTOSE INACTIVE INGREDIENT 3SY5LH9PMK BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 MALEIC ACID INACTIVE INGREDIENT 91XW058U2C BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ BROMOCRIPTINE MESYLATE TABLET [PHYSICIANS TOTAL CARE, INC.] 1
DailyMed RxNorm Mappings#